Chronic, recurrent Lymphocytic Leukemia Active Not Recruiting Phase 2 Trials for Sargramostim (DB00020)

Also known as: Recurrent Chronic Lymphocytic Leukemia

IndicationStatusPhase
DBCOND0112002 (Chronic, recurrent Lymphocytic Leukemia)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02593123Allogeneic Stem Cell Transplantationin Relapsed Hematological Malignancy: Early GVHD ProphylaxisTreatment